Literature DB >> 1892363

Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.

H Hasegawa1, T Matsuoka, Y Goto, I Nonaka.   

Abstract

Intramuscular blood vessels were examined with succinate dehydrogenase stain in skeletal muscle biopsy specimens from 6 patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Almost all arteries had large granular deposits with high succinate dehydrogenase activity in their walls. Electron microscopic examination of serial frozen sections of these biopsies showed that the smooth muscle cells of the strongly succinate dehydrogenase-reactive blood vessels contained markedly proliferated mitochondria, characteristic of patients with MELAS. The presence of strongly succinate dehydrogenase-reactive blood vessels in muscle biopsy specimens provides an important clue toward understanding the underlying pathogenetic mechanism in patients with MELAS as well as another approach to the diagnosis of this disorder.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892363     DOI: 10.1002/ana.410290606

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  25 in total

1.  Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan.

Authors:  Akira Sudo; Shiho Honzawa; Ikuya Nonaka; Yu-Ichi Goto
Journal:  J Hum Genet       Date:  2004-01-17       Impact factor: 3.172

2.  A novel tRNA(Val) mitochondrial DNA mutation causing MELAS.

Authors:  Kurenai Tanji; Petra Kaufmann; Ali B Naini; Jiesheng Lu; Timothy C Parsons; Dong Wang; Joshua Z Willey; Sara Shanske; Michio Hirano; Eduardo Bonilla; Alexander Khandji; Salvatore Dimauro; Lewis P Rowland
Journal:  J Neurol Sci       Date:  2008-03-07       Impact factor: 3.181

3.  The T-C(8356) mitochondrial DNA mutation in a Japanese family.

Authors:  M Sano; M Ozawa; S Shiota; Y Momose; M Uchigata; Y Goto
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

Review 4.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 5.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 6.  Clinical and molecular studies of mitochondrial disease.

Authors:  Y Goto
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

7.  Recurrent respiratory failure in a patient with 3243 mutation in mitochondrial DNA.

Authors:  K Kamakura; H Abe; Y Tadano; R Nakamura; H Kobayashi; S Kawaguchi; N Nagata; T Matsuoka; R Sakuta; I Nonaka
Journal:  J Neurol       Date:  1995-03       Impact factor: 4.849

8.  Mitochondrial encephalomyopathy, lactic acidosis and stroke in adults: two cases.

Authors:  H P Kremer; A Keyser; A R Wintzen; H R Scholte; J G van Hellenberg Hubar; B J Poorthuis; W Ruitenbeek
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

9.  Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis.

Authors:  C M Sue; D S Crimmins; Y S Soo; R Pamphlett; C M Presgrave; N Kotsimbos; M J Jean-Francois; E Byrne; J G Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

10.  MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity.

Authors:  M G Hanna; I P Nelson; J A Morgan-Hughes; N W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.